Science
Mechanism of Action
DMHF functions by inhibiting alpha-MSH-induced melanogenesis, primarily through the suppression of CREB phosphorylation, a process typically activated by protein kinase A. It further reduces the increased cellular production of microphthalmia-associated transcription factor (MITF), tyrosinase, and tyrosinase-related protein-1 (TRP-1) within B16 melanoma cells, thereby disrupting key steps in melanin synthesis.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 In vitro studies in B16 melanoma cells.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Detailed information regarding DMHF's optimal pH range or specific stability characteristics in cosmetic formulations is currently unavailable, necessitating further investigation for precise product development.
Safety
Safety Profile
Independent regulatory bodies such as the Cosmetic Ingredient Review (CIR), Scientific Committee on Consumer Safety (SCCS), or the FDA have not yet issued specific safety assessments for DMHF. Consequently, its comprehensive safety profile for cosmetic use remains largely uncharacterized.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Given the current lack of human clinical studies, comprehensive safety evaluations, and detailed formulation data, DMHF's potential as a skincare ingredient requires significant further research before widespread application.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources